1. Home
  2. DENN vs CADL Comparison

DENN vs CADL Comparison

Compare DENN & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denny's Corporation

DENN

Denny's Corporation

HOLD

Current Price

$6.22

Market Cap

319.8M

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.45

Market Cap

339.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DENN
CADL
Founded
1953
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.8M
339.8M
IPO Year
1989
2021

Fundamental Metrics

Financial Performance
Metric
DENN
CADL
Price
$6.22
$5.45
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$5.45
$19.43
AVG Volume (30 Days)
1.9M
943.3K
Earning Date
02-11-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$457,212,000.00
N/A
Revenue This Year
$6.56
N/A
Revenue Next Year
$1.56
N/A
P/E Ratio
$31.66
N/A
Revenue Growth
0.93
N/A
52 Week Low
$2.85
$4.25
52 Week High
$7.66
$13.68

Technical Indicators

Market Signals
Indicator
DENN
CADL
Relative Strength Index (RSI) 64.62 47.49
Support Level $6.20 $5.45
Resistance Level $6.24 $6.14
Average True Range (ATR) 0.02 0.34
MACD -0.03 -0.05
Stochastic Oscillator 58.33 7.88

Price Performance

Historical Comparison
DENN
CADL

About DENN Denny's Corporation

Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: